Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Recruiting Observational Study
Atrial Fibrillation Cardiac Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 90
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Brigham and Women's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background and Significance: In the United States approximately 220,000 patients undergo cardiac surgery per annum. Among potential complications, the incidence of atrial fibrillation (AF) is estimated at 30 - 60 %, and therefore presents the most common adverse event after cardiac surgery. Multiple complications may be associated with AF: Patients are usually subject to an increased length-of-st…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Elective open heart surgery * Age \> 20 years Exclusion Criteria: * Refusal to participate (patient or health care proxy) * Participation in other pharmacological trials * Lack of data or poor data quality which cannot be analyzed for any heart rhythm in 80% of the postopera…
Contacts

Jakob Wollborn, MD MPH

6175258156

jwollborn@bwh.harvard.edu

CONTACT